Prevalence of Five BRCA1/2 Mutations in Bulgarian Breast Cancer Patients

1. Bulgarian national cancer registry. [Cancer incidence in Bulgaria - data for 2010]. [Internet] 2018 [cited 2018 Nov 27]. Available from: http://www.sbaloncology.bg/en/ncr.html. Bulgarian.Search in Google Scholar

2. National Human Genome Research Institute. Breast cancer information core [Internet] 2017 [cited 2018 Oct 14]. Available from: http://research.nhgri.nih.gov/projects/bic/Search in Google Scholar

3. Peto J, Collins N, Barfoot R, Seal S, Warren W, Rahman N, et al. Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Natl Cancer Inst. 1999;91(11):943-9.10.1093/jnci/91.11.94310359546Search in Google Scholar

4. Serova OM, Mazoyer S, Puget N, Dubois V, Tonin P, Shugart YY, et al. Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer-susceptibility genes? Am J Hum Genet. 1997;60(3):486-95.Search in Google Scholar

5. Neuhausen SL. Founder populations and their uses for breast cancer genetics. Breast Cancer Res. 2000;2(2):77-81.10.1186/bcr3613942611250694Search in Google Scholar

6. Phelan CM, Kwan E, Jack E, Li S, Morgan C, Aubé J, et al. A low frequency of non-founder BRCA1 mutations in Ashkenazi Jewish breast-ovarian cancer families. Hum Mutat. 2002;20(5):352-7.10.1002/humu.1012312402332Search in Google Scholar

7. Górski B, Jakubowska A, Huzarski T, Byrski T, Gronwald J, Grzybowska E, et al. A high proportion of founder BRCA1 mutations in Polish breast cancer families. Int J Cancer 2004;110(5):683-6.10.1002/ijc.2016215146557Search in Google Scholar

8. Dodova RI, Mitkova AV, Dacheva DR, Hadjo LB, Vlahova AI, Hadjieva MST, et al. Spectrum and frequencies of BRCA1/2 mutations in Bulgarian high risk breast cancer patients. BMC Cancer. 2015 Jul.10.1186/s12885-015-1516-2450406626183948Search in Google Scholar

9. National Human Genome Research Institute. Breast cancer information core [Internet] 2017. [cited 2018 Oct 14]. Available from: http://research.nhgri.nih.gov/projects/bic/Member/brca1mutationdatabase.shtml.Search in Google Scholar

10. Fackenthal JD, Olopade OI: Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations. Nat Rev Cancer. 2007;7(12):937-48.10.1038/nrc205418034184Search in Google Scholar

11. Gaj P, Kluska A, Nowakowska D, Balabas A, Piatkowska M, Dabrowska M, et al. High frequency of BRCA1 founder mutations in Polish women with nonfamilial breast cancer. Fam Cancer. 2012;11(4):623-8.10.1007/s10689-012-9560-422864640Search in Google Scholar

12. Møller P, Hagen AI, Apold J, Maehle L, Clark N, Fiane B, et al. Genetic epidemiology of BRCA mutations - family history detects less than 50% of the mutation carriers. Eur J Cancer. 2007;43(11):1713-7.10.1016/j.ejca.2007.04.02317574839Search in Google Scholar

13. De Leeneer K, Coene I, Crombez B, Simkens J, Van den Broecke R, Bols A, et al. Prevalence of BRCA1/2 mutations in sporadic breast/ovarian cancer patients and identification of a novel de novo BRCA1 mutation in a patient diagnosed with late onset breast and ovarian cancer: implications for genetic testing. Breast Cancer Res Treat. 2012;132(1):87-95.10.1007/s10549-011-1544-921553119Search in Google Scholar

14. Hartman AR, Kaldate RR, Sailer LM, Painter L, Grier CE, Endsley RR, et al. Prevalence of BRCA mutations in an unselected population of triple-negative breast cancer. Cancer. 2012;118(11):2787-95.10.1002/cncr.2657622614657Search in Google Scholar

15. Hamel N, Feng BJ, Foretova L, Stoppa-Lyonnet D, Narod SA, Imyanitov E et al. On the origin and diffusion of BRCA1 c.5266dupC (5382insC) in European populations. Eur J Hum Genet. 2011;19(3):300-6.10.1038/ejhg.2010.203Search in Google Scholar

16. Sokolenko AP, Mitiushkina NV, Buslov KG, Bit-Sava EM, Iyevleva AG, Chekmariova EV, et al. High frequency of BRCA1 5382insC mutation in Russian breast cancer patients. Eur J Cancer. 2006;42(10):1380-4.10.1016/j.ejca.2006.01.050Search in Google Scholar

17. Ramus SJ, Kote-Jarai Z, Friedman LS, van der Looij M, Gayther SA, Csokay B, et al. Analysis of BRCA1 and BRCA2 mutations in Hungarian families with breast or breast-ovarian cancer. Am J Hum Genet. 1997;60(5):1242-6.Search in Google Scholar

18. Krajc M, Teugels E, Zgajnar J, Goelen G, Besic N, Novakovic S, et al. Five recurrent BRCA1/2 mutations are responsible for cancer predisposition in the majority of Slovenian breast cancer families. BMC Med Genet. 2008;9:83.10.1186/1471-2350-9-83Search in Google Scholar

19. Couch FJ, Weber BL. Mutations and polymorphisms in the familial early-onset breast cancer (BRCA1) gene. Breast Cancer Information Core. Hum Mutat. 1996;8(1):8-18.10.1002/humu.1380080102Search in Google Scholar

20. Ladopoulou A, Kroupis C, Konstantopoulou I, Ioannidou-Mouzaka L, Schofield AC, Pantazidis A, et al. Germ line BRCA1 & BRCA2 mutations in Greek breast/ovarian cancer families: 5382insC is the most frequent mutation observed. Cancer Lett. 2002;185(1):61-70.10.1016/S0304-3835(01)00845-XSearch in Google Scholar

21. Backe J, Hofferbert S, Skawran B, Dork T, Stuhrmann M, Karstens JH, et al. Frequency of BRCA1 mutation 5382insC in German breast cancer patients. Gynecol Oncol. 1999;72(3):402-6.10.1006/gyno.1998.527010053113Search in Google Scholar

22. Caligo MA, Ghimenti C, Cipollini G, Ricci S, Brunetti I, Marchetti V, et al. BRCA1 germline mutational spectrum in Italian families from Tuscany: a high frequency of novel mutations. Oncogene. 1996;13(7):1483-8.Search in Google Scholar

23. Ferla R, Calò V, Cascio S, Rinaldi G, Badalamenti G, Carreca I et al. Founder mutations in BRCA1 and BRCA2 genes. Ann Oncol. 2007;18 Suppl 6:vi93-8.10.1093/annonc/mdm23417591843Search in Google Scholar